MP04-03 NON-MUSCLE INVASIVE BLADDER CANCER IS ASSOCIATED WITH DECREASED PHYSICAL HEALTH-RELATED QUALITY OF LIFE
Wayne Brisbane(University of California, Los Angeles), George R. Schade(University of Washington), Jonathan L. Wright(Seattle University), Atreya Dash(University of Washington), Brian Winters(University of Washington), John L. Gore(University of Washington), Michael Porter(Seattle University), Sarah K. Holt(University of Washington)
Cited by 0
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Impact of renal impairment on eligibility for adjuvant cisplatin‐based chemotherapy in patients with urothelial carcinoma of the bladder
|Cancer|2006|433
An overview of kidney stone imaging techniques
|Nature Reviews Urology|2016|389
Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
|European Urology|2014|297